Abstract

Objective: The International Society of Urological Pathology (ISUP) has proposed a grading system to classify renal cell carcinoma (RCC). However, classification using biopsy specimens remains problematic and, consequently, the accuracy of a biopsy-based diagnosis is relatively poor. This study aims to combine clinical and immunohistochemical (IHC) factors for the prediction of high ISUP grade clear cell RCC (ccRCC) in an attempt to complement and improve the accuracy of a biopsy-based diagnosis.Methods: A total of 362 ccRCC patients were enrolled in this study and used for the training set. We performed IHC analysis of 18 protein markers on standard tissue sections using an automated stainer. Multivariate logistic regression models were developed to evaluate independent predictors for high ISUP grade. We evaluated different prediction models using receiver operating characteristic (ROC) curves and area under the ROC curve (AUC) analysis. A nomogram for the derivation of an integrated score for predicting high ISUP grade ccRCC and a calibration curve were also plotted. Finally, an internal validation cohort was examined to evaluate the performance of our integrated scoring system and nomogram.Results: Multivariate logistic analyses revealed seven credible candidates for predicting high grade ISUP. These were age, tumor diameter, surgery, and CK7, Ki-67, PTEN, and MTOR protein expression. The ROC curves for the clinical, IHC and integrated models were compared in the training set, and the AUC for each was 0.731, 0.744, and 0.801, respectively. DeLong's test showed that the integrated model was significantly better at predicting high ISUP grade, when compared with the other models. Internal validation confirmed the good performance of the integrated score in predicting ISUP grade.Conclusion: We have developed a nomogram integrating clinical and immunohistochemical parameters to predict high ISUP grade for M0 ccRCC patients. This nomogram may offer potentially useful information during preoperative individualized patient risk assessment, and consequently may help urologists when planning personalized management regimens.

Highlights

  • Renal cell carcinoma (RCC) is one of the most common malignancies of the genitourinary system, and constitutes 3% of adult malignant tumors and accounts for 2% of all cancer mortality [1]

  • We investigated the value of integrating clinical profiles and IHC biomarkers in facilitating the diagnosis of high International Society of Urological Pathology (ISUP) grade Clear cell RCC (ccRCC)

  • Clinical Characteristics of Patients Classified According to ISUP Grade

Read more

Summary

Introduction

Renal cell carcinoma (RCC) is one of the most common malignancies of the genitourinary system, and constitutes 3% of adult malignant tumors and accounts for 2% of all cancer mortality [1]. In 2012, the International Society of Urological Pathology (ISUP) Consensus Conference made recommendations regarding prognostic characteristics, staging, and immunohistochemical (IHC) evaluation and classification, in an attempt to improve the prognostic value of these factors in the assessment of the various histomorphological phenotypes of RCC [6, 7]. By applying these recommendations, increased tumor grade was found to be significantly associated with poor patient outcomes [8]. In 2016 the International Agency for Research on Cancer replaced the Fuhrman system with a new grading standard based on the WHO/ISUP grading system, which is summarized in Supplementary Table S1 [9, 10]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call